Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes
|
By HospiMedica International staff writers Posted on 16 Nov 2022 |

Absology Co., Ltd. (Gyeonggi-do, Korea) is participating in MEDICA 2022 where the company is exhibiting its POC FIA (Fluorescence Immunoassay) analyzer that uses microfluidic technology for the accurate quantitative diagnosis of concentration of biomarkers for a range of diseases.
At MEDICA 2022, Absology is showcasing its ABSOL POCT analyzer that uses FIA technology to quantitatively diagnose the concentration of biomarkers. It has a test time of only five minutes and features a vivid expressed GUI along with a convenient built-in printer. Alongside ABSOL, the company is showcasing the ABSOL HS high-sensitive ELISA analyzer for early disease screening. ABSOL HS can detect Femtogram level molecules using Absology’s proprietary PIFA (Photooxidation Induced Fluorescence Amplification) technology. It has a test time of only 30 minutes and requires just 20uL of blood sample. Compact and affordable, the portable and light weight ABSOL HS is a flexible platform for any kind of ELISA protocol. Absology offers a wide test menu for the ABSOL and ABSOL HS systems, including PSA, Testosterone, Vitamin D, TSH, FreeT4, Thyroid Combo, Cortisol, PCT, COVID-19 IgM/IgG, COVID-19 Ag, COVID-19 Neutralizing Antibody, and Influenza A/B.
Related Links:
Absology Co., Ltd.
Latest MEDICA 2022 News
Channels
Artificial Intelligence
view channelCritical Care
view channel
AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
After cardiac arrest, predicting whether a patient will recover neurologically is one of the most difficult decisions faced by clinicians and families. This challenge is even greater in hospitals with... Read more
Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
Long-term sleep and health monitoring often relies on wearable devices that require batteries, regular charging, and frequent maintenance, which can reduce comfort and long-term adherence.... Read moreSurgical Techniques
view channel
New AI Approach to Improve Surgical Imaging
Surgeons often rely on visual judgment to distinguish between healthy and diseased tissue or to avoid damaging critical structures during procedures. This assessment is subjective and limited by what the... Read more
Dual-Energy Catheter Brings New Flexibility to AFib Ablation
Abbott has secured CE Mark approval for the TactiFlex Duo Ablation Catheter, Sensor-Enabled, for the treatment of atrial fibrillation (AFib). AFib is a common and progressive cardiac arrhythmia affecting... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
World Health Expo (WHX) in Dubai, formerly Arab Health, which takes place from 9-12 February 2026 at the Dubai Exhibition Centre (DEC), has officially announced the launch of a new dedicated Biotech &... Read more
WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
World Health Expo (WHX), formerly Arab Health, will bring together the UAE’s health authorities and leading healthcare sector bodies when the exhibition debuts at the Dubai Exhibition Centre (DEC) from... Read more
Interoperability Push Fuels Surge in Healthcare IT Market
Hospitals still struggle to reconcile data scattered across electronic health records, laboratory systems, and billing platforms, undermining care coordination and operational efficiency.... Read more








